Figure 1. The vicious cycle induced by low T3 circulating levels leads to further reduction in T3 cardiac tissue availability as shown on the left side. The potential effects of systemic T3 replacement therapy on cardiac T3 metabolism and TR receptors in AMI are shown on the right.
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
